Ceapro Inc. (CRPOF)
- Previous Close
0.1830 - Open
0.1830 - Bid --
- Ask --
- Day's Range
0.1830 - 0.1830 - 52 Week Range
0.1150 - 0.4270 - Volume
3,000 - Avg. Volume
8,400 - Market Cap (intraday)
14.328M - Beta (5Y Monthly) 1.38
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date May 23, 2024 - May 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.
www.ceapro.comRecent News: CRPOF
Performance Overview: CRPOF
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRPOF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRPOF
Valuation Measures
Market Cap
14.26M
Enterprise Value
9.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.04
Price/Book (mrq)
0.71
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-48.89%
Return on Assets (ttm)
-11.30%
Return on Equity (ttm)
-15.66%
Revenue (ttm)
9.63M
Net Income Avi to Common (ttm)
-4.71M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
8.84M
Total Debt/Equity (mrq)
8.07%
Levered Free Cash Flow (ttm)
-3.2M
Research Analysis: CRPOF
Company Insights: CRPOF
CRPOF does not have Company Insights